TF

Tanja Fauti

Hoffmann-La Roche: 3 patents #991 of 3,238Top 35%
RA Roche Glycart Ag: 2 patents #32 of 86Top 40%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
Overall (All Time): #489,140 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11987632 Antibodies binding to HLA-A2/MAGE-A4 Tina WEINZIERL, Lydia Jasmin Hanisch, Alexander BUJOTZEK, Alejandro Carpy Gutierrez Cirlos, Stefan Klostermann +4 more 2024-05-21
11952421 Bispecific antibodies against CD3EPSILON and ROR1 Minh Diem Vu, Klaus Strein, Oliver Ast, Anne Freimoser-Grundschober, Ralf Hosse +10 more 2024-04-09
11639397 Bispecific antibodies specific for T-cell activating antigens and a tumor antigen and methods of use Peter Bruenker, Christiane Neumann, Christian Klein, Pablo Umana 2023-05-02
11608376 Tumor-targeted agonistic CD28 antigen binding molecules Guy Georges, Thomas Hofer, Ralf Hosse, Christian Klein, Ekkehard Moessner +5 more 2023-03-21
10851171 Method for the selection of antibodies against BCMA Minh Diem Vu, Klaus Strein, Ekkehard Moessner, Ralf Hosse, Oliver Ast +5 more 2020-12-01
10766967 Bispecific T cell activating antigen binding molecules Marina BACAC, Sabine Imhof-Jung, Christian Klein, Stefan Klostermann, Ekkehard Moessner +5 more 2020-09-08
10253104 Bispecific antibodies against CD3ϵ and BCMA Minh Diem Vu, Klaus Strein, Oliver Ast, Marina BACAC, Lydia Jasmin Hanisch +12 more 2019-04-09
10087250 Fc-free antibodies comprising two fab-fragments and methods of use Peter Bruenker, Christiane Neumann, Christian Klein, Pablo Umana 2018-10-02
10077315 Bispecific antibodies against CD3 and BCMA Minh Diem Vu, Klaus Strein, Ekkehard Moessner, Ralf Hosse, Oliver Ast +5 more 2018-09-18
9963513 Method for the selection of antibodies against BCMA Minh Diem Vu, Klaus Strein, Ekkehard Moessner, Ralf Hosse, Oliver Ast +5 more 2018-05-08